Clinical Trials Browser

Completed × Imiquimod × Lymphoid × Clear all

NCT03559413 2023-12-04

Patient-individualized Peptide Vaccination Based on Tumor-specific Mutations in Children and Young Adults With Primary/Relapsed ALL

Phase 1/2 Completed

LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT02802943 2022-11-28

iVAC-CLL01: Patient-individualized Peptide Vaccination After First Line Therapy of CLL

Phase 2 Completed

LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell